When serum irisin and body fat percentage were added into model 3 simultaneously, the effect of circulating irisin on insulin resistance was attenuated into marginally significant (OR (95 % CI): 0.879 (0.770–1.003), p = .055), but the effect of body fat percentage on insulin resistance showed little change. The gene discussed is FNDC5; the disease is Insulin resistance.